WHAT THIS PAPER ADDS This study introduces a new visual grading score that improves the accuracy of FDG-PET/CT in the detection of prosthetic vascular graft infections (PVGIs). This will not only improve and speed up the diagnosis of PVGI but also allow for the monitoring of medical and surgical therapy thereof. Morbidity, mortality, and costs of treatment may significantly decrease in the near future because of the enhanced diagnostic accuracy and improved therapeutic management.
INTRODUCTION
Vascular graft infections, although relatively rare (incidence rate between 1% and 6%) 1 require an immediate and definite diagnosis 2 as they carry a high mortality and morbidity risk. 3 In 2005, a first report on the diagnostic accuracy of positron emission tomography/computed tomography (PET/CT) with 18 F-fludeoxyglucose (FDG) suggested an increased accuracy of FDG-PET/CT compared with the current standard contrast enhanced CT in the diagnostic assessment of patients with suspected vascular graft infection. 4 Since then other groups have reconfirmed the higher sensitivity of PET/CT in the detection of graft infections. 4e7 Signs of graft infection on PET/CT imaging are fluid formations or fat stranding and/or FDG avid lesions adjacent to the graft, as FDG accumulates in metabolically active cells and thus detects infectious tissues. 8 Increased glucose metabolism may be detected earlier and/or in less severe stages of infectious processes by PET/CT than graft thickening, perigraft soft tissue enhancement, pseudoaneurysm formation, or gas collection typically detected by CT imaging, e These authors contributed equally.
which occur in later and/or more severe stages of the infectious process. The higher sensitivity of FDG-PET/CT than CT imaging has led to a lower specificity and false positive (FP) rate, both of which are often the consequence of foreign body reactions caused by the graft. 9 Knowledge of typical FDG uptake patterns of foreign body reactions, 10 a mildly increased and not focal FDG uptake along the graft, may prevent FP imaging interpretation.
Today, data on diagnostic accuracy of FDG-PET/CT in the detection of vascular graft infections are still scarce and comparability is hampered by the variability of patient populations, imaging protocols, and time points of imaging 4e7 (Table 1) . Additionally, data on the perigraft maximum standardized uptake value (SUV max ), a semi-quantitative index of graft infection, are still limited. 11 More studies are required to define the diagnostic accuracy of FDG-PET/CT, justifying the use of this more complex and expensive technique in routine practice. The diagnostic accuracy of FDG-PET/CT in a well-defined prospective cohort of patients with suspected graft infections using microbiologic results as the standard of reference was assessed. An additional aim was to validate a new diagnostic imaging score for FDG-PET/ CT, which may help to further increase its specificity.
METHODS

Study design and data collection
The Vasgra (vascular graft) Cohort Study is a prospective observational cohort study with ongoing enrolment of patients, aged >18 years receiving any type of vascular graft operation at the University hospital of Zurich. Standardized data collection forms on the index vascular operation, demographic, clinical, laboratory, and follow up information are completed every 6 months by physicians and study nurses. The Vasgra Cohort was approved by the local Institutional Ethics Committee. New prosthetic vascular graft infections (PVGIs) as well as foreign body reaction, bleeding, thrombosis, and arterial disruption of vascular grafts have been documented since May 1, 2013. Endpoints are core reviewed and validated by a team of vascular surgeons and infectious disease specialists. Diagnosis of PVGI followed the definition proposed by FitzGerald et al. 12 The gold standard for PVGI diagnosis was a positive microbiological culture of the deep tissue around the vascular prosthesis obtained by open biopsy, or a positive microbiological culture of an explanted vascular graft. However, clinical, laboratory, and histopathological results were also taken into account. Surgical classifications of PVGI were done according to the Szilagyi criteria. 13 As per protocol, patients with suspected vascular graft infection received a combined FDG-PET/CT prior to antimicrobial treatment, or as soon as possible after the start of either surgical or antimicrobial treatment.
Patient population
This study was a prospective analysis of consecutive patients undergoing combined FDG-PET/CT between May 2013 and May 2014 at our institution. Thirty-four patients (3 women, 31 men; median [IQR] age 67 [62e76] years) with suspected vascular graft infection were enrolled.
FDG-PET/CT was successfully performed with diagnostic image quality in all 34 patients with suspected vascular graft infections. Baseline characteristics are presented in Table 2 . Twenty patients underwent open vascular surgery. The index surgical operation included total arch or descending aorta replacement (n ¼ 8), aorto-bi-iliac graft (n ¼ 7), femoro-femoral crossover bypass (n ¼ 3), and iliofemoral or femoro-tibial bypass (n ¼ 2). Fourteen patients had endovascular aortic repair of either abdominal (EVAR, n ¼ 5) or thoracic aortic aneurysms (TEVAR, n ¼ 5), or they had an endovascular placement of a stent graft in the iliac artery (n ¼ 4). The median (IQR) time between initial operation and inclusion in the present study was 213 (63e 644) days. Inclusion in the study in the case of endovascular surgery was a median (IQR) 70 (35e593) days and for open surgery 443 (110e671) days after the index operation.
PET/CT data acquisition
Patients fasted for at least 4 hours and had no insulin injections 4 hours prior to FDG administration. Body weight, height, and blood glucose levels were measured prior to injection of FDG. In non-diabetic patients, blood glucose levels <8 mmol/L and in diabetic patients blood glucose levels <12 mmol/L were accepted for imaging. After intravenous injection of body weight adapted FDG, patients rested for a standardized uptake time of 60 minutes. All scans were performed on an integrated PET/CT system (Discovery VCT; GE Healthcare, Milwaukee, WI, USA).
Data were acquired with the patient in the supine position with arms overhead. Low dose CT for attenuation correction was acquired from the mid-thigh to the vertex of the skull with the following scan parameters: tube voltage, 140 kVp; tube current time product, 10e80 mAs/slice; pitch of 1.4; collimation, 64 Â 0.625 mm; rotation time, 0.5 ms; and field of view (FOV), 50 cm. Directly after CT data acquisition, PET data were acquired using the three dimensional mode (3D) with a fixed scan duration of 2 minutes per bed position and a FOV of 157 mm. Emission data were corrected for randoms, dead time, scatter, and attenuation. CT data for attenuation correction and anatomical referencing were reconstructed with a slice thickness of 3.75 mm and an increment of 3.0 mm using a filtered back reconstruction algorithm. Attenuation corrected axial PET images were reconstructed using a standard iterative ordered subset expectation maximization (OSEM) 3D algorithm (matrix size, 256 Â 256, Fourier rebinning, 3D OSEM with 8 iterations, 16 subsets).
Image analysis
All FDG-PET/CT images were independently analyzed by two experienced nuclear medicine physicians (B.S. and L.H.) on an AW Workstation Version 4.4 (GE Healthcare Biosciences, Pittsburgh, PA, USA). Readers were blinded to all clinical patient data. Whole body datasets were analyzed for secondary diagnosis, that is, infectious foci not in the vicinity of a graft, or other relevant or malignant findings. Two different subjective imaging scores were used to establish or to rule out PVGI: The first, established, score considered the FDG uptake pattern in the graft: focal uptake was considered as infectious, while diffuse FDG uptake was considered to be non-infectious (e.g., foreign body reaction). 4 The second score was a new semi-quantitative assessment using a new five point visual grading score, which took into account the FDG uptake patterns and CT information as follows: grade 1, normal background activity; grade 2, mildly increased, but diffuse FDG uptake along the graft (mild uptake: less than twice the blood pool activity in the ascending aorta; strong uptake: more than twice the blood pool activity in the ascending aorta); grade 3, focal, but only mild FDG uptake or strong diffuse FDG uptake along the graft; grade 4, focal and intense FDG uptake (AEdiffuse FDG uptake along the graft); grade 5, focal and intense FDG uptake plus fluid collections/abscess formation. Imaging examples for each score are presented in Fig. 1 . Score values of 3, 4, and 5 were considered to be positive for graft infection, and score values of 1 and 2 as negative. Final scores for further analysis were defined by consensus reading.
For quantitative measurements of metabolic activity of the tracer in all grafts SUV max was calculated using in-built software.
Statistical analyses
Statistical analysis was performed using commercially available software (Stata, Version 13, StataCorp, College Station, TX, USA).
Sensitivity, specificity, negative predictive values (NPVs), and positive predictive values (PPVs) were determined for the diagnosis of vascular graft infections with the use of a binary and a five point visual grading score considering the criteria described in the method section. Inter-observer agreements were evaluated for both the binary and the 5 point Linkert scale scoring system with Cohen's kappa statistics. Results for inter-observer agreement were construed in accordance with the classification of Landis and Koch 14 as follows: values of 0.2 or less as poor, values of 0.21e0.4 as fair, values of 0.41e0.6 as moderate, values of 0.61e0.8 as good, and values of 0.81e 1.0 as excellent agreement; in case of disagreement a consensus reading was performed. The SUV max cut point at the receiver operator curve (ROC) yielding the highest accuracy of PVGI diagnosis was determined.
RESULTS
Twenty-seven of 34 patients (79%) had a microbiologically proven Szilagyi III graft infection; one patient with antibiotic pre-treatment remained culture negative, although histopathological findings showed clear evidence of graft infection. In seven patients (21%) graft infection was ruled out. Twelve patients (35%) did not receive any antibiotic treatment prior to FDG-PET/CT, while in 22 patients (65%) antibiotic treatment had already started (median 13 days [IQR 6e72] days) prior to imaging. Owing to fulminant clinical presentation at the time of diagnosis, three patients were scanned after urgent surgical intervention. Median (IQR) C-reactive protein was 35.5 (17e85) mg/L, being 
Diagnostic performance
Using a five point visual grading score of graft infections, reader 1 (L.H.) and reader 2 (B.S.) scored images as shown in Table 3 . Both readers scored the same six patients negative and the same 24 positive for vascular graft infections. Interobserver agreement for the five point visual grading score was good (k ¼ .72, p < .001) with differences occurring between scores of 1 and 2 (n ¼ 1) as well as between score 3 and 4 (n ¼ 1) and between scores of 4 and 5 (n ¼ 5).
FDG-PET/CT correctly recognized 27 cases with graft infection as true positive (TP) using the five point visual grading score. One patient was diagnosed FP, six patients were correctly classified as true negative (TN), and no patients were rated false negative (FN) by both readers (patients without antibiotic treatment: TP ¼ 9, FP ¼ 0, TN ¼ 3, FN ¼ 0; patients on antibiotic treatment: TP ¼ 18, FP ¼ 1, TN ¼ 3, FN ¼ 0). ROC analysis provided an area under the curve (AUC) of 0.99 (standard error 0.01). Overall sensitivity, specificity, PPV, NPV, and accuracy of PET/CT for the diagnosis of graft infections with the use of a five point visual grading score (score ! 3): 100% (95% CI: 87e100), 86% (42e100), 96% (82e100), 100% (54e100), and 97% (85e100); patients without antibiotic treatment: 100% (66e100), 100% (29e100), 100% (66e100), 100% (29e100), and 100% (74e100); patients with antibiotic treatment: 100% (82e100), 75% (19e99), 95% (74e100), 100% (29e100), 96% (77e100).
Focal FDG uptake was found in 27 patients and diffuse uptake in seven patients, resulting in 26 TP, six TN, one FP, and one FN finding; thus the calculated sensitivity, specificity, PPV, NPV, and accuracy of PET/CT was 96% (81e 100), 86% (42e100), 96% (81e100), 86% (42e100) and 94% (80e100), respectively. ROC analysis provided AUC of 0.91 (standard error 0.07). The interobserver agreement for the binary score was excellent (k ¼ 0.91, p < .001).
Median (IQR) SUV max in all vascular grafts was 6.3 (4.4e 8.5), whereby median SUV max was higher in patients with proven graft infections than in patients with no infected grafts (6.7 [5.8e10] vs. 3.2 [2.8e3.6]; p < .001) (Fig. 2) . In our study population, six of seven patients (86%) without graft infection had SUV max 3.6, while all patients (27/27) with graft infections had SUV max ! 3.8 (Table 2) . Hence an SUV max of !3.8 was determined as a cut off value to differentiate between infected and non-infected grafts (100% [87e100] sensitivity and 86% [42e100] specificity). In two patients with PVGIs a coincident malignant disease was diagnosed, one hypopharyngeal carcinoma and one gastrointestinal stromal tumor.
Seven patients had no graft infection. FDG-PET/CT provided a conclusive clinical diagnosis in line with the patient's symptoms in all patients, including infections other than a PVGI: pneumonia (n ¼ 1), colitis (n ¼ 2), diverticulitis (n ¼ 1), sinusitis (n ¼ 1), and spondylodiscitis (n ¼ 1). One of the seven patients had Dressler syndrome (not detected by PET/CT). All of these patients had a 6 month follow up visit at our institution and neither clinical information nor subsequent imaging pointed towards a PVGI.
DISCUSSION
Suspected vascular graft infections are still primarily investigated by CT scan despite the superiority of FDG-PET/CT over CT in the diagnostic assessment of patients with PVGIs suggested in recent years. 2 Results of this study support the knowledge that the diagnostic accuracy of FDG-PET/CT in patients with suspected PVGI may even be higher than previously reported, provided that patients are imaged prior to antibiotic treatment, and that the newly introduced visual grading score is used for image interpretation.
Patient population
The diagnosis of a PVGI is often delayed and as yet there are no clear diagnostic criteria available. Detection of microorganisms in the perigraft tissue may serve as a gold standard for this complicated diagnosis. Ninety-six percent of our patients had a microbiologically proven graft infection, whereas in previous studies 4e6 positive culture results were available in only 0e64% of the study population, presumably due to prolonged antibiotic therapy prior to hospital admission. The current study population included fewer patients on antimicrobial treatment prior to imaging (22/34, 65%), reflecting a mixed study population of low grade and acute graft infections. Fukuchi et al. 4 enrolled 26 patients with suspected graft infection (plus 7 asymptomatic controls); 25 patients (79%) had received antibiotic treatment at the time of imaging. Seventeen of 25 (68%) patients had been treated with intensive antibiotic treatment in the study population of Bruggink et al. 7 Clinical presentation may be acute in some patients with vascular graft infections, especially in the presence of highly virulent pathogens, 15 requiring immediate antimicrobial treatment. After the start of effective antibiotic treatment, a trend to declining metabolic activity in infections is expected, 7 which might reduce the sensitivity of FDG-PET/CT.
High levels of blood glucose and/or high levels of blood insulin may reduce the sensitivity of FDG PET/CT, although data in the literature are somewhat controversial. 16 Fukuchi et al. 4 excluded patients with diabetes, whereas Keidar et al. 5 included eight patients with diabetes in their study population of 39 patients, six of them with normal blood glucose levels; one of these six was diagnosed as FN, which was probably due to high levels of insulin. None of the five patients in this study with diabetes was rated FN or FP; which might account for the improved diagnostic accuracy compared with the other studies mentioned above.
Diagnostic accuracy
Data on diagnostic accuracy of FDG-PET/CT in the detection of PVGI are sparse and reliability is hampered by large variability of patient populations. Only four groups have prospectively investigated patient populations of more than 10 patients with suspected vascular graft infections. 4e7 All of these studies have demonstrated that FDG-PET/CT is a highly sensitive method for the diagnosis of PVGIs (sensitivities 91%, 93%, 93%, and 98%). However, specificity was rather low (64%, 70%, 76%, and 91%). FP findings may occur in the presence of an infected hematoma, a lymphocele in the vicinity of the graft, 10 or as a result of foreign body reactions.
4e6,10,17 Moreover, limitations exist in the distinction of foreign body reaction and low grade infection in the presence of inhomogeneous FDG uptake in PET/CT. 6 Therefore, the five point visual grading score introduced herein for Figure 2 . Receiver operator curve (ROC) of prosthetic vascular graft infection using the SUV max as a quantitative measurement of tracer uptake. A SUV max of !3.8 was determined as cut off value to differentiate between infected and non-infected grafts (100% sensitivity and 75% specificity). SUV max ¼ maximum standardized uptake value; AUC ¼ area under the curve.
FDG-PET/CT evaluation combines the intensity of FDG uptake, as suggested by Bruggink et al., 7 with uptake pattern (focal or diffuse) as well as CT information (i.e., fluid or gas formations). The diagnostic accuracy in the present study is higher than in all previous studies, 4e7 reaching 100% accuracy in the subgroup with no antimicrobial treatment prior to imaging. Whether this is due to a favorable recruitment, or to the beneficial performance of the newly introduced imaging score, will be matter of further studies.
SUV max cut off value
An FP PVGI diagnosis may lead to unnecessarily complex multimodal treatment, whereas a FN diagnosis is associated with high morbidity. 2 An adequate SUV max cut off value may be helpful in clinical routine to differentiate graft infection from a non-infectious process especially in equivocal cases. Spacek et al. 6 suggested an SUV max of 1.7 as a cut off value, while Tokuda et al. 11 suggested an SUV max > 8 to distinguish infected grafts from non-infected grafts. The former determined the SUV max cut off value using ROC analyses for the best accuracy of FDG-PET/CT in detecting PVGI, while the latter measured the optimal SUV max cut off value by determining maximal sensitivity and specificity at the ROC curve (Youden test). Apparently, methodological methods were different and reported patient populations too heterogeneous with regard to clinical presentation and sample size and do not yet allow reliable definition of SUV max cut off values. Further validating study results are mandatory before introducing SUV max cut off values into routine clinical use. However, SUV max cut off values could serve as an interesting monitoring tool for the response to antibiotic treatment in the future.
Limitations of the study
The present study population is heterogeneous, similar to all populations of previous studies. 4e7 However, by means of the standardized cohort procedures the percentage of patients receiving antimicrobial treatment prior to imaging was reduced. Further improvement might even increase the accuracy of FDG-PET/CT in future studies, however, due to the severity of the disease, it will be a difficult task. Additionally, the usefulness of PET/CT is limited by its relative unavailability in emergency cases.
CONCLUSION
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